Download free PDF

Medical Polymers Market Size & Share 2023 to 2032

Market Size by Product (Medical Fibers & Resins [PVC, PP, PE, Polystyrene], Medical Elastomers [SBC, Rubber Latex], Biodegradable Medical Plastics), Application (Medical Devices & Equipment, Medical Packaging), & Forecast.

Report ID: GMI1126
   |
Published Date: December 2022
 | 
Report Format: PDF

Download Free PDF

Medical Polymers Market Size

Medical Polymers Market size was valued at USD 20 billion in 2022 and is expected to observe over 8% CAGR through 2032. Rapid growth of the pharmaceutical devices sector over the past few years has significantly impacted the industry expansion.

Medical Polymers Market

In the current scenario, chronic medical ailments such as infections, cardiovascular issues, generic medical conditions, and other disorders are becoming increasingly prevalent. This has necessitated the development of advanced pharmaceutical devices and sophisticated medical treatments. Medical-grade polymers have established themselves as an essential component of the global healthcare ecosystem. They are employed in a wide range of devices, from surgical tools to implants and catheters. Single-use medical devices are also less likely to transmit healthcare-associated illnesses than reusable equipment as they are radiolucent, allowing light weighting, with minimized stress shielding.

Stringent regulations for governing new products to hamper medical polymers market demand

Presence of stringent norms for assessing the credibility of new products is expected to negatively impede the industry expansion. A significant concern regarding the use of polymers in the medical device industry is its safety and reusability. Recent studies have linked DEHP to a range of adverse effects in the reproductive tract, liver, kidneys, the heart, and lungs. These factors may have a crucial impact on the product uptake.

 

Medical Polymers Market Analysis

Global Medical Polymer Market, By Product

Medical polymers market share from biodegradable medical plastics segment is expected to grow at more than 10% CAGR through 2032. Owing to their product benefits, such as strong chemical and microbiological resistance, low weight and costs, biodegradable polymers are likely to see significant expansion in medical applications.  The manufacturing of these polymers revolves around less energy compared to traditional plastics, resulting in fewer GHG emissions that harm the planet. Since the material can be molded into exact proportions as per requirement, it calls for high demand in the syringe industry.
 

Global Medical Polymer Market, By Application

Based on application, medical packaging segment is projected to showcase more than 8% CAGR through 2032. The stringent need for the effective packaging of medical devices and pharmaceuticals coupled with the increasing hygiene awareness is driving the market growth. Medical polymer barrier packaging and films protect the products from vibration, stress, magnetic fields, and compression. Key regulatory authorities, such as the European FDA and the U.S. F.D.A. are encouraging medical plastics usage in disposables, which is boosting the growth of the medical polymers market.
 

Global Medical Polymer Market

MEA (Middle East and Africa) medical polymers market size is likely to depict over 9% CAGR through 2032. The increasing demand for polymers in medical packaging applications is contributing to industry share in the region. The stringent requirements for effective pharmaceutical and medical device packaging have led to the development of a diverse variety of innovative medical polymer films. Plastics that can withstand radiation sterilization have made way for a wide range of polymer compositions for rigid and semirigid thermoforms, as well as films with thicknesses ranging from 0.5 to 10.0 mil. Such technological advancements are likely to boost the market dynamics in the region.
 

Medical Polymers Market Share

Some leading medical polymer companies include

  • Bayer Material Science AG
  • BASF SE
  • Celanese Corporation
  • Eastman Chemical
  • DSM N.V.
  • Evonik Industries AG
  • The Dow Chemical Company
  • Exxon Mobil Corporation
  • Sinopec
  • Lubrizol Corporation
  • SABIC Innovative Plastics
  • Huntsman Corporation
  • Solvay SA.

To unlock optimized market participation, these firms are turning to several marketing strategies, including mergers and acquisitions, partnerships, new product launches, etc.

 

COVID-19 Impact

COVID-19 pandemic had a positive impact on the medical polymers market. The product demand was significantly influenced by the growing requirement for single use syringes for vaccinations. Additionally, the thriving pharma industry has also been a key contributor to the growth of the polymers industry, driven by the surging need for medication packaging. It is expected that the medical polymers industry is likely to see considerable upheaval in the years to come with the global threat of various infectious and chronic illnesses on the rise.
 

The medical polymers market research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in Kilo Tons and revenue in USD Million from 2018 to 2032 for the following segments:

by Product

  • Medical Fibers and resin
    • PVC
    • PP
    • PE
    • PS
    • Others
  • Medical Elastomer
    • Styrene Block Copolymer
    • Rubber latex (NR + Butyl Rubber + Silicone rubber)
    • Others
  • Biodegradable medical plastic

by Application

  • Medical devices and equipment
  • Medical packaging
  • Others (cardio, tissue culture)

by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Australia
    • Japan
    • Indonesia
    • Malaysia
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • GCC
    • South Africa
       
Authors:  Kiran Pulidindi, Kunal Ahuja

Research methodology, data sources & validation process

This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.

Our 6-step research process

  1. 1. Research design & analyst oversight

    At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.

    Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.

  2. 2. Primary research

    Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.

  3. 3. Data mining & market analysis

    Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.

  4. 4. Market sizing

    Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.

  5. 5. Forecast model & key assumptions

    Every forecast includes explicit documentation of:

    • ✓ Key growth drivers and their assumed impact

    • ✓ Restraining factors and mitigation scenarios

    • ✓ Regulatory assumptions and policy change risk

    • ✓ Technology adoption curve parameter

    • ✓ Macroeconomic assumptions (GDP growth, inflation, currency)

    • ✓ Competitive dynamics and market entry/exit expectations

  6. 6. Validation & quality assurance

    The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.

    Our triple-layer validation process ensures maximum data reliability:

    • ✓ Statistical Validation

    • ✓ Expert Validation

    • ✓ Market Reality Check

Trust & credibility

10+
Years in Service
Consistent delivery since establishment
A+
BBB Accreditation
Professional standards & satisfaction
ISO
Certified Quality
ISO 9001-2015 Certified Company
150+
Research Analysts
Across 10+ industry verticals
95%
Client Retention
5-year relationship value

Verified data sources

  • Trade publications

    Security & defense sector journals and trade press

  • Industry databases

    Proprietary and third-party market databases

  • Regulatory filings

    Government procurement records and policy documents

  • Academic research

    University studies and specialist institution reports

  • Company reports

    Annual reports, investor presentations, and filings

  • Expert interviews

    C-suite, procurement leads, and technical specialists

  • GMI archive

    13,000+ published studies across 30+ industry verticals

  • Trade data

    Import/export volumes, HS codes, and customs records

Parameters studied & evaluated

Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →

Frequently Asked Question(FAQ) :
What is the size of the global medical polymers market?
Market size for medical polymers was valued at USD 20 billion in 2022 and is expected to observe over 8% CAGR through 2032, driven by the rapid growth of the pharmaceutical devices industry.
Why is the demand for biodegradable medical plastics increasing?
Medical polymers industry share from biodegradable medical plastics segment is expected to grow at more than 10% CAGR through 2032, as it utilizes less energy than traditional plastics and is better for the environment.
Which factors are driving the growth of MEA medical polymers industry?
MEA medical polymers size is likely to depict over 9% CAGR through 2032, owing to increasing product demand for medical packaging applications.
Who are the key players in the global medical polymers market?
Some of the leading medical polymer manufacturers include Bayer Material Science AG, BASF SE, Eastman Chemical, DSM N.V., Celanese Corporation, Evonik Industries AG, The Dow Chemical Company, Exxon Mobil Corporation, Sinopec, Lubrizol Corporation, SABIC Innovative Plastics, Huntsman Corporation, and Solvay SA.
Medical Polymers Market Scope
  • Medical Polymers Market Size

  • Medical Polymers Market Trends

  • Medical Polymers Market Analysis

  • Medical Polymers Market Share

Authors:  Kiran Pulidindi, Kunal Ahuja
Explore Our Licensing Options:

Starting at: $2,450

Premium Report Details:

Base Year: 2022

Companies Profiled: 14

Tables & Figures: 529

Countries Covered: 17

Pages: 320

Download Free PDF

We use cookies to enhance user experience. (Privacy Policy)